Partial hepatectomy and liver transplantation are potentially curative treatments in selected
patients with hepatocellular carcinoma (HCC). Unfortunately, a high postoperative tumor …

The decision curve is a graphical summary recently proposed for assessing the potential
clinical impact of risk prediction biomarkers or risk models for recommending treatment or …

Purpose To construct a nomogram with the albumin-bilirubin (ALBI) grade to assess the long-
term outcomes of patients with early-stage hepatocellular carcinoma (HCC) after …

The prognosis of patients with hepatocellular carcinoma (HCC) and intrahepatic
cholangiocarcinoma (ICC) is a research hotspot. This study aimed to incorporate important …

Background and Aims Surgery is the primary curative option in patients with hepatocellular
carcinoma (HCC). Current prognostic models for HCC are developed on datasets of …

Background Extrahepatic recurrence and early intrahepatic recurrence of hepatocellular
carcinoma after hepatic resection are indicative of poor prognoses. We aimed to develop …

Background. In developed countries, the most common gynecologic malignancy is
endometrial carcinoma (EC), making the identification of EC biomarkers extremely essential …

Aim Hepatectomy is the main curative method for patients with hepatocellular carcinoma
(HCC) in China. Unfortunately, high recurrence rate after hepatectomy poses negative …

As an indispensable part for cancer precision medicine, biomarkers and signatures for
predicting cancer prognosis and therapeutic benefits were urgently required. The purpose of …

Objectives Integrin beta‐like 1 (ITGBL1) is involved in the migration and invasion of several
cancers; however, its roles in the development and progression of hepatocellular carcinoma …